Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2023-07-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
The "short solution-oriented program" intervention group will be applied for 6 weeks, a total of 7 lesson hours.
Short Solution Focused Approach Program
It will be a psychoeducational approach aimed at developing preventive and protective properties against addiction.
Control Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Short Solution Focused Approach Program
It will be a psychoeducational approach aimed at developing preventive and protective properties against addiction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteering to participate in the research.
* Not receiving any psychological counseling and treatment
* Getting a sufficiently high score in any of the sub-dimensions according to the Substance Use Risk Profile Scale
Exclusion Criteria
* Getting a low score in all sub-dimensions according to the Substance Use Risk Profile Scale
* Being diagnosed with substance abuse or substance abuse
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ufuk DOĞAN
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ufuk DOĞAN
Lecturer PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ufuk Doğan, PhD
Role: PRINCIPAL_INVESTIGATOR
Hasan Kalyoncu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ufuk Doğan
Elâzığ, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/69
Identifier Type: -
Identifier Source: org_study_id